Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia
NCT00008697Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Nov 1998
- Primary completion
- Apr 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by Washington University School of Medicine. Started Nov 1998; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00008697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008697.